Alzheimer’s: 2nd innovative treatment nears US approval

Douglas researchers are conducting important research on Alzheimer’s disease. Drs Sylvia Villeneuve and Judes Poirier were interviewed by TVA Nouvelle to talk about their research into Alzheimer’s disease, in particular the identification of tau and amyloid in the brains of individuals at very high risk of developing Alzheimer’s disease in later years. This work, carried … Read more

Stop-AD Centre

Stop Alzheimer's disease

The main objective of the StoP-Alzheimer Center is to pursue innovative studies on the “pre-symptomatic” phase of Alzheimer’s disease using measures of various disease indicators, including genetic variants, brain imaging, cerebrospinal fluid collection, neurosensory markers, as well as lifestyle questionnaires, cognitive and medical assessments. Director  Sylvia Villeneuve, PhD Associate Director Judes Poirier, PhD, MD (Hon), CQ … Read more